Glaukos® iStent Infinite Trabecular Micro-Bypass System in Subjects With Mild to Moderate Primary Open-angle Glaucoma

ConditionGlaucoma
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age35+
SponsorGlaukos Corporation

About this trial

Prospective, multicenter, single-arm study of the iStent infinite in adult pseudophakic or phakic subjects with mild to moderate primary open angle glaucoma who have not failed conventional medical and surgical treatment

Eligibility criteria

Qualifiers

Diagnosis of primary open-angle glaucoma

Phakic or pseudophakic

Age 35 years or older

Disqualifiers

Traumatic, uveitic, neovascular, angle-closure glaucoma or

glaucoma associated with vascular disorders

Active corneal inflammation or edema

Retinal disorders not associated with glaucoma

Trial design

Treatments tested in this trial

  • iStent Infinite

Treatment groups

245 Participants
are divided into 1 treatment group

Sponsors and collaborators